The Top CROs in the United States – Contract Research Organization
PART (A)
PART (A)
The Top CROs in the United States – Contract Research Organization
The Top CROs in the United States – Contract Research Organization
Updated February 8, 2019
contract Research Organization (CRO) provides all kinds of research services on contract. Increasingly, CROs are filling in the capacity gaps of the in-house research team for pharmaceutical and clinical research. Some CROs provide the entire gamut of services, starting from drug discovery to clinical trials and further
contract Research Organization (CRO) provides all kinds of research services on contract. Increasingly, CROs are filling in the capacity gaps of the in-house research team for pharmaceutical and clinical research. Some CROs provide the entire gamut of services, starting from drug discovery to clinical trials and further
The two CRO terms – Contract Research Organization and Clinical Research Organization – are often used interchangeably. Whatever the full form is, CROs typically provide support to biopharma and medical devices companies for conducting clinical trials and preparing and submitting FDA filings. However, recently, CROs are playing a greater role in research activities as companies outsource various research and trial functions.
The two CRO terms – Contract Research Organization and Clinical Research Organization – are often used interchangeably. Whatever the full form is, CROs typically provide support to biopharma and medical devices companies for conducting clinical trials and preparing and submitting FDA filings. However, recently, CROs are playing a greater role in research activities as companies outsource various research and trial functions.
Top 10 CRO Companies of 2019
Top 10 CRO Companies of 2019
Source – Igeahub
Based on analysis by IgeaHub, the top CRO Companies in the United States, based on Revenues are as following:
Based on analysis by IgeaHub, the top CRO Companies in the United States, based on Revenues are as following:
1. LabCorp (Laboratory Corporation of America) is headquartered in Burlington, North Carolina. While a majority of their revenue is from operating one of the largest networks of clinical laboratories in the world, LabCorp also owns Covance, a major CRO based in Princeton, New Jersey and has 36 Service Portfolio units.
1. LabCorp (Laboratory Corporation of America) is headquartered in Burlington, North Carolina. While a majority of their revenue is from operating one of the largest networks of clinical laboratories in the world, LabCorp also owns Covance, a major CRO based in Princeton, New Jersey and has 36 Service Portfolio units.
2. IQVIA (formerly known as Quintiles IMS Holdings) is based in Durham, North Carolina. They focus primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services. Of all the companies on this list, they have the highest number of service portfolio units.
2. IQVIA (formerly known as Quintiles IMS Holdings) is based in Durham, North Carolina. They focus primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services. Of all the companies on this list, they have the highest number of service portfolio units.
3. SyneosHealth (formerly InVentiv Research and INC Research) is based in Raleigh, North Carolina. They focus on their ability to deliver integrated end-to-end solutions to develop and commercialize clinical therapies.
3. SyneosHealth (formerly InVentiv Research and INC Research) is based in Raleigh, North Carolina. They focus on their ability to deliver integrated end-to-end solutions to develop and commercialize clinical therapies.
4. Parexel is based in Waltham, Massachusetts and is a global provider of biopharmaceutical process. They also conduct clinical trials on behalf of clients who are looking to expedite their drug approval process.
4. Parexel is based in Waltham, Massachusetts and is a global provider of biopharmaceutical process. They also conduct clinical trials on behalf of clients who are looking to expedite their drug approval process.
5. PRA Health Sciences is based in Raleigh, North Carolina. They provide two separate workstreams: clinical research and data solutions. They provide outsourced services to the pharmaceutical and biotechnology services to clients worldwide in the two workstreams.
5. PRA Health Sciences is based in Raleigh, North Carolina. They provide two separate workstreams: clinical research and data solutions. They provide outsourced services to the pharmaceutical and biotechnology services to clients worldwide in the two workstreams.
7. Charles River Laboratories Internation Inc (CRL) is based in Wilmington, Massachusetts. They provide specialized services in a variety of clinical and pre-clinical research.
7. Charles River Laboratories Internation Inc (CRL) is based in Wilmington, Massachusetts. They provide specialized services in a variety of clinical and pre-clinical research.
8. ICON Public Limited Corporation is headquartered in Dublin, Ireland. They offer a range of consulting, development and commercialization services via their global network in 37 countries. This is the first company on this list which is not based in the United States.
8. ICON Public Limited Corporation is headquartered in Dublin, Ireland. They offer a range of consulting, development and commercialization services via their global network in 37 countries. This is the first company on this list which is not based in the United States.
9. WuXi Apptec is headquartered in Shanghai, China. They offer five core operation services: small molecule R&D and manufacturing, biologics R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, medical device testing, and molecular testing and genomics. This is the only company on the list which is based in Asia, and the only other company not based in the United States.
9. WuXi Apptec is headquartered in Shanghai, China. They offer five core operation services: small molecule R&D and manufacturing, biologics R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, medical device testing, and molecular testing and genomics. This is the only company on the list which is based in Asia, and the only other company not based in the United States.
10. Medpace Holdings, Inc is headquartered in Cincinnati, Ohio. Their services focus on the development of drugs and medical devices.
10. Medpace Holdings, Inc is headquartered in Cincinnati, Ohio. Their services focus on the development of drugs and medical devices.
PART (B)
PART (B)
Contract research organization
Contract research organization
From Wikipedia, the free encyclopedia
Jump to navigationJump to search
This article needs to be updated. In particular: figures cited are from 2007-2015. Please update this article to reflect recent events or newly available information.
This article needs to be updated. In particular: figures cited are from 2007-2015. Please update this article to reflect recent events or newly available information.
(June 2018)
(June 2018)
A contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, clinical trials management, and pharmacovigilance. CROs are designed to reduce costs for companies developing new medicines and drugs in niche markets. They aim to simplify entry into drug markets, and simplify development, as the need for large pharmaceutical companies to do everything ‘in house’ is now redundant.[citation needed] CROs also support foundations, research institutions, and universities, in addition to governmental organizations (such as the NIH, EMA, etc.).[1]
A contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, clinical trials management, and pharmacovigilance. CROs are designed to reduce costs for companies developing new medicines and drugs in niche markets. They aim to simplify entry into drug markets, and simplify development, as the need for large pharmaceutical companies to do everything ‘in house’ is now redundant.[citation needed] CROs also support foundations, research institutions, and universities, in addition to governmental organizations (such as the NIH, EMA, etc.).[1]
Contents
Contents
- 1Definition, regulatory aspects
- 2Market size and growth
- 3List of companies by annual revenue
- 4See also
- 5References
Definition, regulatory aspects[edit]
Definition, regulatory aspects[edit]
The International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, a 2015 Swiss NGO of pharmaceutical companies and others, defined a contract research organization (CRO), specifically pertaining to clinical trials services as:[6]:10 "A person or an organization (commercial, academic, or other) contracted by the sponsor to perform one or more of a sponsor's trial-related duties and functions."
The International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, a 2015 Swiss NGO of pharmaceutical companies and others, defined a contract research organization (CRO), specifically pertaining to clinical trials services as:[6]:10 "A person or an organization (commercial, academic, or other) contracted by the sponsor to perform one or more of a sponsor's trial-related duties and functions."
It further details the sponsor's responsibilities in its good clinical practice guidelines:[6]:22-23
It further details the sponsor's responsibilities in its good clinical practice guidelines:[6]:22-23
(5.2.1) A sponsor may transfer any or all of the sponsor's trial-related duties and functions to a CRO, but the ultimate responsibility for the quality and integrity of the trial data always resides with the sponsor. The CRO should implement quality assurance and quality control.
(5.2.1) A sponsor may transfer any or all of the sponsor's trial-related duties and functions to a CRO, but the ultimate responsibility for the quality and integrity of the trial data always resides with the sponsor. The CRO should implement quality assurance and quality control.
(5.2.2) Any trial-related duty and function that is transferred to and assumed by a CRO should be specified in writing. The sponsor should ensure oversight of any trial-related duties and functions carried out on its behalf, including trial-related duties and functions that are subcontracted to another party by the sponsor’s contracted CRO(s).
(5.2.2) Any trial-related duty and function that is transferred to and assumed by a CRO should be specified in writing. The sponsor should ensure oversight of any trial-related duties and functions carried out on its behalf, including trial-related duties and functions that are subcontracted to another party by the sponsor’s contracted CRO(s).
(5.2.3) Any trial-related duties and functions not specifically transferred to and assumed by a CRO are retained by the sponsor.
(5.2.3) Any trial-related duties and functions not specifically transferred to and assumed by a CRO are retained by the sponsor.
(5.2.4) All references to a sponsor in this guideline also apply to a CRO to the extent that a CRO has assumed the trial-related duties and functions of a sponsor.
(5.2.4) All references to a sponsor in this guideline also apply to a CRO to the extent that a CRO has assumed the trial-related duties and functions of a sponsor.
Market size and growth[edit]
Market size and growth[edit]
As of 2013, there were over 1,100 CROs in the world, despite continued trends toward consolidation. Many CROs have been acquired while others have gone out of business.[7] The industry is fragmented, with the top 10 companies controlling 56% of the market in 2008[8] and 55% in 2009.[9][10] One estimate from 2007 had the size of the market set to reach $24 billion in 2010[11] and another estimate from 2009 set to grow at a rate of 8.5% through 2015.[12]
As of 2013, there were over 1,100 CROs in the world, despite continued trends toward consolidation. Many CROs have been acquired while others have gone out of business.[7] The industry is fragmented, with the top 10 companies controlling 56% of the market in 2008[8] and 55% in 2009.[9][10] One estimate from 2007 had the size of the market set to reach $24 billion in 2010[11] and another estimate from 2009 set to grow at a rate of 8.5% through 2015.[12]
List of companies by annual revenue[edit]
List of companies by annual revenue[edit]
Laboratory Corporation of America Holdings (Covance) ($10.44B revenues in 2017)
Laboratory Corporation of America Holdings (Covance) ($10.44B revenues in 2017)
IQVIA ($9.74B revenues in 2017)
IQVIA ($9.74B revenues in 2017)
Syneos Health ($2.67B revenues in 2017)
Syneos Health ($2.67B revenues in 2017)
PAREXEL International Corporation ($2.44B revenues in 2017)
PAREXEL International Corporation ($2.44B revenues in 2017)
PRA Health Sciences ($2.26B revenues in 2017)
PRA Health Sciences ($2.26B revenues in 2017)
Pharmaceutical Product Development (PPD) ($1.90B revenues in 2017)
Pharmaceutical Product Development (PPD) ($1.90B revenues in 2017)
Charles River Laboratories International Inc (CRL) ($1.86B revenues in 2017)
Charles River Laboratories International Inc (CRL) ($1.86B revenues in 2017)
Wuxi Apptec ($1.01B revenues in 2017)
Wuxi Apptec ($1.01B revenues in 2017)
Medpace Holdings, Inc ($0.44B revenues in 2017)
Medpace Holdings, Inc ($0.44B revenues in 2017)
See also[edit]
See also[edit]
References[edit]
References[edit]
^ "The CRO Market" Archived 2013-07-03 at the Wayback Machine, Association of Clinical Research Organizations.
^ "The CRO Market" Archived 2013-07-03 at the Wayback Machine, Association of Clinical Research Organizations.
^ Jump up to:a b E6(R2) Good Clinical Practice International Council on Harmonisation good clinical practice, 66 ppp, amended Nov 2016, accessed 30 Jan 2018
^ Jump up to:a b E6(R2) Good Clinical Practice International Council on Harmonisation good clinical practice, 66 ppp, amended Nov 2016, accessed 30 Jan 2018
^ "CRO Industry Could See More Consolidation, Experts Say"Archived 2013-09-26 at the Wayback Machine outsourcing-pharma.com, 2013-06-20 Retrieved 2013-09-24
^ "CRO Industry Could See More Consolidation, Experts Say"Archived 2013-09-26 at the Wayback Machine outsourcing-pharma.com, 2013-06-20 Retrieved 2013-09-24
^ The Top 10 Contract Research Organizations -Positioning, performance and SWOT analyses bioportfolio.com, 5 February 2010
^ The Top 10 Contract Research Organizations -Positioning, performance and SWOT analyses bioportfolio.com, 5 February 2010
^ "The CRO Market Outlook!publisher =globalbusinessinsights.com" (PDF). Archived from the original (PDF) on December 18, 2010. Retrieved February 5,2013.
^ "The CRO Market Outlook!publisher =globalbusinessinsights.com" (PDF). Archived from the original (PDF) on December 18, 2010. Retrieved February 5,2013.
^ "Reportlinker Adds The CRO Market Outlook: Emerging Markets, Leading Players and Future Trends. | Trends & Events > Trends from". AllBusiness.com. 2009-09-21. Archived from the original on August 31, 2010. Retrieved 2010-08-03.
^ "Reportlinker Adds The CRO Market Outlook: Emerging Markets, Leading Players and Future Trends. | Trends & Events > Trends from". AllBusiness.com. 2009-09-21. Archived from the original on August 31, 2010. Retrieved 2010-08-03.
^ Ed Miseta (11 February 2016). "Clinical Outsourcing Market To See Continued Growth Through 2020". www.clinicalleader.com.
^ Ed Miseta (11 February 2016). "Clinical Outsourcing Market To See Continued Growth Through 2020". www.clinicalleader.com.
^ Luca Dezzani (2018-03-15). "Top 10 Global CROs 2018". IgeaHub Pharmaceutical Club. Retrieved 2018-06-25.
^ Luca Dezzani (2018-03-15). "Top 10 Global CROs 2018". IgeaHub Pharmaceutical Club. Retrieved 2018-06-25.
show
show
show
show
Pharmaceutical industry in the United States
Pharmaceutical industry in the United States
show
show
Pharmaceutical industry by country
Pharmaceutical industry by country
PART (C)
PART (C)
The Rapid Growth of the CRO Industry: Analysis & Forecasts
The Rapid Growth of the CRO Industry: Analysis & Forecasts
by The Business Research Company, on April 30, 2018
The global market for clinical trial services to biopharmaceutical, biotechnology, and medical device companies is forecast to grow at 12% year on year up to 2021, according to a new report. That is an acceleration from its rate of 10% up to 2017 which raised its value to $44.4 billion. The businesses that provide outsourcing in clinical trials are CROs.
The global market for clinical trial services to biopharmaceutical, biotechnology, and medical device companies is forecast to grow at 12% year on year up to 2021, according to a new report. That is an acceleration from its rate of 10% up to 2017 which raised its value to $44.4 billion. The businesses that provide outsourcing in clinical trials are CROs.
What Is a CRO?
What Is a CRO?
Contract research organizations (CROs) offer solutions for the conduct of clinical trials, including:
Contract research organizations (CROs) offer solutions for the conduct of clinical trials, including:
Initial drug discovery solutions
Initial drug discovery solutions
Toxicology studies
Toxicology studies
Bio-analytical services
Bio-analytical services
Central laboratory functions
Central laboratory functions
Cite monitoring
Cite monitoring
Data management services
Data management services
Vigilance
Vigilance
Bio-statistics
Bio-statistics
Study and development program design and consulting
Study and development program design and consulting
Regulatory affairs
Regulatory affairs
A variety of post-marketing surveillance services
A variety of post-marketing surveillance services
CRO Industry Overview
CRO Industry Overview
Declining growth in the pharmaceutical market is affecting the CRO industry, though not in the obvious way. Recently, the double digit growth rates of pharmaceutical and biotechnology companies have been shrinking to single digits, while their returns on investment have also shrunk. Pharmaceutical and biotechnology companies have therefore been confronted with the need to lower their drug production and development costs. This has led many of them to evaluate cost-saving options such as outsourcing clinical trials.
Declining growth in the pharmaceutical market is affecting the CRO industry, though not in the obvious way. Recently, the double digit growth rates of pharmaceutical and biotechnology companies have been shrinking to single digits, while their returns on investment have also shrunk. Pharmaceutical and biotechnology companies have therefore been confronted with the need to lower their drug production and development costs. This has led many of them to evaluate cost-saving options such as outsourcing clinical trials.
Several companies in this sector have already adopted this strategy and outsourced their processes to specialist service providers such as CROs, and it is expected that this will increase in the future in order to contain the high cost of new drug development which is currently running at $2 billion on average.
Several companies in this sector have already adopted this strategy and outsourced their processes to specialist service providers such as CROs, and it is expected that this will increase in the future in order to contain the high cost of new drug development which is currently running at $2 billion on average.
CRO Market Segments by Development Phase
CRO Market Segments by Development Phase
The contract research organization market can be segmented on the basis of the type of services provided, which vary according to the development phase. The segments consist of the following:
The contract research organization market can be segmented on the basis of the type of services provided, which vary according to the development phase. The segments consist of the following:
Drug discovery
Drug discovery
Preclinical studies to determine relative toxicity
Preclinical studies to determine relative toxicity
Phase I to test basic safety and pharmacology
Phase I to test basic safety and pharmacology
Phase II efficacy evaluation
Phase II efficacy evaluation
Phase III advanced efficacy and safety testing to provide enough data for valid statistical conclusions required by the regulatory authority
Phase III advanced efficacy and safety testing to provide enough data for valid statistical conclusions required by the regulatory authority
Phase IV continuous testing following the granting of regulatory authority approval for marketing
Phase IV continuous testing following the granting of regulatory authority approval for marketing
Other services including pharmacovigilance, bio-statistics, clinical data management, site management, monitoring, regulatory services, protocol development, and medical writing
Other services including pharmacovigilance, bio-statistics, clinical data management, site management, monitoring, regulatory services, protocol development, and medical writing
The largest segment in 2017 was drug discovery, which involves identifying from a pool of 10,000-15,000 compounds a promising molecule that has the potential to become a new medicine. Drug discovery accounted for about 33% of the contract research organization market. Its dominance is a reflection of the high failure rate at this early stage of drug development; most possibilities are eliminated at this stage.
The largest segment in 2017 was drug discovery, which involves identifying from a pool of 10,000-15,000 compounds a promising molecule that has the potential to become a new medicine. Drug discovery accounted for about 33% of the contract research organization market. Its dominance is a reflection of the high failure rate at this early stage of drug development; most possibilities are eliminated at this stage.
The next largest segment in 2017, however, was not Phase II but Phase III. This reflected the fact that the sizes of the later stages of pharma R&D vary over time; they are influenced by how many innovations succeeded in earlier stages. Thus the chart shown, which is for 2017, could look somewhat different in a year or two.
The next largest segment in 2017, however, was not Phase II but Phase III. This reflected the fact that the sizes of the later stages of pharma R&D vary over time; they are influenced by how many innovations succeeded in earlier stages. Thus the chart shown, which is for 2017, could look somewhat different in a year or two.
CRO Market Segments by Therapeutic Area
CRO Market Segments by Therapeutic Area
Another way of categorizing the market for CRO services is by the disease area of the drugs or equipment being researched. Here the segments consist of research directed at finding solutions for cancer, infectious diseases, central nervous system disorders, cardiovascular diseases and other therapeutic areas, which include diabetes and various metabolic, dermatology, and respiratory diseases.
Another way of categorizing the market for CRO services is by the disease area of the drugs or equipment being researched. Here the segments consist of research directed at finding solutions for cancer, infectious diseases, central nervous system disorders, cardiovascular diseases and other therapeutic areas, which include diabetes and various metabolic, dermatology, and respiratory diseases.
By therapeutic area, oncology was the largest segment of the CRO market in the latest year, accounting for about 25% of the total. Part of the reason for the importance of the oncology segment is the boost to cancer drug R&D development resulting from the US Federal Drugs Administration loosening its regulatory requirements for new cancer drugs. The changes being implemented or considered by the FDA include allowing organ-on-chip trials to be substituted for animal trials in the early stages of the process, allowing the inclusion of non-trial data from patients, and changing the end-point benchmark from proving that the drug extends overall survival to showing that it prolongs the time a patient lives without the disease getting worse.
By therapeutic area, oncology was the largest segment of the CRO market in the latest year, accounting for about 25% of the total. Part of the reason for the importance of the oncology segment is the boost to cancer drug R&D development resulting from the US Federal Drugs Administration loosening its regulatory requirements for new cancer drugs. The changes being implemented or considered by the FDA include allowing organ-on-chip trials to be substituted for animal trials in the early stages of the process, allowing the inclusion of non-trial data from patients, and changing the end-point benchmark from proving that the drug extends overall survival to showing that it prolongs the time a patient lives without the disease getting worse.
Segmental growth rates, however, differ from market size. For example, the metabolic disease segment, which researches for treatments for diabetes and glandular disorders, is growing faster than the oncology segment. This is mainly due to demand for CRO services for new drug development through academia-industry collaborations.
Segmental growth rates, however, differ from market size. For example, the metabolic disease segment, which researches for treatments for diabetes and glandular disorders, is growing faster than the oncology segment. This is mainly due to demand for CRO services for new drug development through academia-industry collaborations.
The CRO Market by Geographies
The CRO Market by Geographies
North America is the largest region for the production of CRO services, at $18.8 billion, while CRO consumption in North America is worth $20.8 billion, or about 47% of the global total. The large North American market size is due to the presence of many pharmaceutical companies and extensive drug development activity in the region, especially in the USA. The production/consumption difference results from the use by US pharmaceutical firms of lower-cost offshore locations for some CRO activities, although most US outsourced activity remains within the country.
North America is the largest region for the production of CRO services, at $18.8 billion, while CRO consumption in North America is worth $20.8 billion, or about 47% of the global total. The large North American market size is due to the presence of many pharmaceutical companies and extensive drug development activity in the region, especially in the USA. The production/consumption difference results from the use by US pharmaceutical firms of lower-cost offshore locations for some CRO activities, although most US outsourced activity remains within the country.
At 31% of the total, Asia Pacific has the second largest share of the CRO production market, though its share of the consumption market is only two-thirds of that. This is due to pharmaceutical and biotechnology companies in the United States and Western Europe increasingly outsourcing their core research activities to CROs in developing countries in order to contain costs.
At 31% of the total, Asia Pacific has the second largest share of the CRO production market, though its share of the consumption market is only two-thirds of that. This is due to pharmaceutical and biotechnology companies in the United States and Western Europe increasingly outsourcing their core research activities to CROs in developing countries in order to contain costs.
Because of this, many multi-national CROs are themselves now expanding their operations to developing countries in Asia Pacific, Latin America, and Eastern Europe to take advantage of lower costs for conducting clinical trials in these regions compared to the US and European countries. Thus, the economic conditions in developed countries will drive the demand for outsourcing services from Asia Pacific, providing that concerns about intellectual property rights and quality standards are met.
Because of this, many multi-national CROs are themselves now expanding their operations to developing countries in Asia Pacific, Latin America, and Eastern Europe to take advantage of lower costs for conducting clinical trials in these regions compared to the US and European countries. Thus, the economic conditions in developed countries will drive the demand for outsourcing services from Asia Pacific, providing that concerns about intellectual property rights and quality standards are met.
In Western Europe, as in North America, the relation between the production and consumption markets is the reverse of that in Asia Pacific, at 27% of global consumption against 21% of global production. The difference here is also due to R&D outsourcing to emerging economy suppliers by Western European drug manufacturers.
In Western Europe, as in North America, the relation between the production and consumption markets is the reverse of that in Asia Pacific, at 27% of global consumption against 21% of global production. The difference here is also due to R&D outsourcing to emerging economy suppliers by Western European drug manufacturers.
The Competitive Landscape
The Competitive Landscape
Historically, the CRO market was highly fragmented, but increasing M&A activity has led to consolidation. Five CROs hold over 33% of the global market.
Historically, the CRO market was highly fragmented, but increasing M&A activity has led to consolidation. Five CROs hold over 33% of the global market.
“The market has changed in the sense that you have seen a lot of CRO companies just like ours are either merging or acquiring data companies. This is where the development is — I think they understood the power of aligning big data and using it to streamline clinical developments.”
“The market has changed in the sense that you have seen a lot of CRO companies just like ours are either merging or acquiring data companies. This is where the development is — I think they understood the power of aligning big data and using it to streamline clinical developments.”
— Senior Researcher, IQVIA
— Senior Researcher, IQVIA
IQVIA is the largest CRO with a 12.4% share of the market, followed by Laboratory Corporation of America Holdings, ICON Plc, PAREXEL and PPD. The companies tend to specialize, however, so that another company, not in the overall top five, is the largest in the pre-clinical studies segment. That is Charles River Laboratories, which in 2017 had 17% of that part of the market.
IQVIA is the largest CRO with a 12.4% share of the market, followed by Laboratory Corporation of America Holdings, ICON Plc, PAREXEL and PPD. The companies tend to specialize, however, so that another company, not in the overall top five, is the largest in the pre-clinical studies segment. That is Charles River Laboratories, which in 2017 had 17% of that part of the market.
Where to Learn More about the CRO Industry
Where to Learn More about the CRO Industry
Read the Global Contract Research Organizations Global Market Report 2018 from The Business Research Company for information on the following:
Read the Global Contract Research Organizations Global Market Report 2018 from The Business Research Company for information on the following:
Markets Covered: Contract Research Organizations Production, Contract Research Organizations Consumption, Outsourced R&D Market By Service Type (Development Phase), Outsourced R&D Market By Therapeutic Area.
Markets Covered: Contract Research Organizations Production, Contract Research Organizations Consumption, Outsourced R&D Market By Service Type (Development Phase), Outsourced R&D Market By Therapeutic Area.
Top Contract Research Organizations Covered: IQVIA, Laboratory Corporation of America Holdings, ICON Plc, PAREXEL and PPD.
Top Contract Research Organizations Covered: IQVIA, Laboratory Corporation of America Holdings, ICON Plc, PAREXEL and PPD.
Regions: North America, Asia Pacific, Western Europe, Eastern Europe, South America, Middle East, Africa.
Regions: North America, Asia Pacific, Western Europe, Eastern Europe, South America, Middle East, Africa.
Countries: USA, China, Germany, UK, Japan, France, India, Italy, Australia, Spain, Russia, Brazil.
Countries: USA, China, Germany, UK, Japan, France, India, Italy, Australia, Spain, Russia, Brazil.
Time Series: Five years historic and forecast.
Time Series: Five years historic and forecast.
Other Data: CRO Market Size as a Percentage of GDP by Country, per Capita Average CRO Expenditure by Country.
Other Data: CRO Market Size as a Percentage of GDP by Country, per Capita Average CRO Expenditure by Country.
Data Segmentations: CRO production and consumption country and regional historic and forecast data, competitor sales and market shares; outsourced R&D market by service type (development phase) historic and forecast data by region and country; outsourced R&D market by therapeutic area historic and forecast data by region and country.
Data Segmentations: CRO production and consumption country and regional historic and forecast data, competitor sales and market shares; outsourced R&D market by service type (development phase) historic and forecast data by region and country; outsourced R&D market by therapeutic area historic and forecast data by region and country.
Sourcing and Referencing: Pharmaceutical drugs production and consumption country and regional historic and forecast data, competitor sales and market shares; pharmaceutical drugs market by segments historic and forecast data by region and country; ratios of market size and growth to related markets, population, GDP, pharmaceutical drugs indicators comparison.
Sourcing and Referencing: Pharmaceutical drugs production and consumption country and regional historic and forecast data, competitor sales and market shares; pharmaceutical drugs market by segments historic and forecast data by region and country; ratios of market size and growth to related markets, population, GDP, pharmaceutical drugs indicators comparison.
Interested to know more? Here is a list of similar reports from The Business Research Company:
Interested to know more? Here is a list of similar reports from The Business Research Company:
About The Business Research Company
About The Business Research Company
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has research professionals at its offices in the U.K., India, and the U.S. as well as a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, and technology.
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has research professionals at its offices in the U.K., India, and the U.S. as well as a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, and technology.
The Business Research Company’s management team has more than 20 years of varied business research experience. They have delivered hundreds of research projects to the senior management of some of the world’s largest organizations. The Business Research Company’s consultants have master’s qualifications from top institutes and include MBAs, MSCs, CFAs, and CAs. The Business Research Company’s consultants gain training and qualifications from the Market Research Society and are trained in advanced research practices, techniques, and ethics.
The Business Research Company’s management team has more than 20 years of varied business research experience. They have delivered hundreds of research projects to the senior management of some of the world’s largest organizations. The Business Research Company’s consultants have master’s qualifications from top institutes and include MBAs, MSCs, CFAs, and CAs. The Business Research Company’s consultants gain training and qualifications from the Market Research Society and are trained in advanced research practices, techniques, and ethics.
Additional Articles by the Publisher
Additional Articles by the Publisher
SHARE
SHARE
Clinical Research Training
Clinical Research Training
11/2/2018, 1:04:35 AM
PART (D)
PART (D)
Revenue Forecasting & Recognition at Contract Research Organizations: The Alternative to Spreadsheets
Revenue Forecasting & Recognition at Contract Research Organizations: The Alternative to Spreadsheets
by John Rounseville | Jun 8, 2018 | Salesforce
Because of the nature of their businesses, Contract Research Organizations (CROs) need tools that allow for reliable revenue forecasting and recognition. Some CROs need to manage hundreds of forecasts at a time.
Because of the nature of their businesses, Contract Research Organizations (CROs) need tools that allow for reliable revenue forecasting and recognition. Some CROs need to manage hundreds of forecasts at a time.
These revenue forecasts are important for overall planning and for making staffing decisions. When the future month-to-month workload can be reliably forecasted, appropriate management decisions can be made on both the sales and delivery fronts.
These revenue forecasts are important for overall planning and for making staffing decisions. When the future month-to-month workload can be reliably forecasted, appropriate management decisions can be made on both the sales and delivery fronts.
The go-to revenue forecasting tool of choice for many CROs is spreadsheets—either Microsoft Excel or Google Sheets.
The go-to revenue forecasting tool of choice for many CROs is spreadsheets—either Microsoft Excel or Google Sheets.
Advantages to using spreadsheets for CRO revenue forecasting & recognition
Advantages to using spreadsheets for CRO revenue forecasting & recognition
Spreadsheets tend to be the “system of least resistance” for a lot of data management applications. Here are some of the reasons:
Spreadsheets tend to be the “system of least resistance” for a lot of data management applications. Here are some of the reasons:
Spreadsheet files are free
Spreadsheet files are free
There’s no incremental cost to the organization when someone creates a new spreadsheet. There’s no software to procure or configure for revenue forecasting and recognition.
There’s no incremental cost to the organization when someone creates a new spreadsheet. There’s no software to procure or configure for revenue forecasting and recognition.
Spreadsheets are universal
Spreadsheets are universal
Almost everyone has access to a spreadsheet application. A spreadsheet can be emailed to anyone within the organization and to people outside the organization.
Almost everyone has access to a spreadsheet application. A spreadsheet can be emailed to anyone within the organization and to people outside the organization.
Spreadsheets can be collaborative
Spreadsheets can be collaborative
With the advent of cloud-based spreadsheet applications such as Excel Online and Google Sheets, multiple people can simultaneously work on the same spreadsheet.
With the advent of cloud-based spreadsheet applications such as Excel Online and Google Sheets, multiple people can simultaneously work on the same spreadsheet.
Spreadsheets are powerful
Spreadsheets are powerful
Excel has hundreds of functions as does Google Sheets.
The desktop version of Excel is well know for its macro capabilities. Google Sheets has scripts.
The desktop version of Excel is well know for its macro capabilities. Google Sheets has scripts.
It’s worth noting that macros, which can be used to lock down ranges of a spreadsheet, do not work in the collaborative online version of Excel.
It’s worth noting that macros, which can be used to lock down ranges of a spreadsheet, do not work in the collaborative online version of Excel.
Spreadsheets are flexible
Spreadsheets are flexible
A user doesn’t need an administrator to make a structural change to a spreadsheet. They simply make the change themselves.
A user doesn’t need an administrator to make a structural change to a spreadsheet. They simply make the change themselves.
Disadvantages to spreadsheets for CRO revenue forecasting & recognition
Disadvantages to spreadsheets for CRO revenue forecasting & recognition
There are a number of disadvantages to using spreadsheets for revenue recognition compared to using a true shared database.
There are a number of disadvantages to using spreadsheets for revenue recognition compared to using a true shared database.
A spreadsheet is not a true multi-user system
A spreadsheet is not a true multi-user system
While online spreadsheets can be shared with multiple users, there’s no way to give each of the users access to only what they’re responsible for. In other words, spreadsheets are a “free for all” among users in terms of information viewing and editing.
While online spreadsheets can be shared with multiple users, there’s no way to give each of the users access to only what they’re responsible for. In other words, spreadsheets are a “free for all” among users in terms of information viewing and editing.
Spreadsheets are not necessarily secure
Spreadsheets are not necessarily secure
The fact that spreadsheets are universal can also be a security risk. If a spreadsheet is not password protected, the data can be shared with anyone, anywhere by emailing an attachment.
The fact that spreadsheets are universal can also be a security risk. If a spreadsheet is not password protected, the data can be shared with anyone, anywhere by emailing an attachment.
Spreadsheets do not scale well
Spreadsheets do not scale well
Let’s say a revenue forecast has these three general dimensions:
Let’s say a revenue forecast has these three general dimensions:
The number of contracts
The number of contracts
The contract duration
The contract duration
The month by month figures for each contract (salesperson forecast, manager adjustment, actuals)
The month by month figures for each contract (salesperson forecast, manager adjustment, actuals)
If we assume:
If we assume:
200 past and future contracts
200 past and future contracts
24 months average contract duration
24 months average contract duration
3 sets of month by month figures
3 sets of month by month figures
That works out to 14,400 spreadsheet cells.
That works out to 14,400 spreadsheet cells.
This volume of cells means a lot of scrolling, clicking worksheet tabs and/or switching among multiple spreadsheet files. Finding the data for a specific contract can be time consuming.
This volume of cells means a lot of scrolling, clicking worksheet tabs and/or switching among multiple spreadsheet files. Finding the data for a specific contract can be time consuming.
Spreadsheets are only partially structured
Spreadsheets are only partially structured
Spreadsheets are partially structured to the extent that they don’t have a predefined database model. Most new spreadsheets are a blank slate and can take any form. Any user can add columns and rows to an existing sheet.
Spreadsheets are partially structured to the extent that they don’t have a predefined database model. Most new spreadsheets are a blank slate and can take any form. Any user can add columns and rows to an existing sheet.
Spreadsheets don’t always protect the integrity of data
Spreadsheets don’t always protect the integrity of data
Data can get corrupted fairly easily in a spreadsheet. Examples are when a formula has not been extended through its expected range or when the wrong cell is referenced in a formula.
Data can get corrupted fairly easily in a spreadsheet. Examples are when a formula has not been extended through its expected range or when the wrong cell is referenced in a formula.
Spreadsheets do not have an inherent hierarchy
Spreadsheets do not have an inherent hierarchy
CROs often get repeat business from existing customers. As such, there can be multiple contract opportunities related to a customer. These can include contracts that were won in the past, those that were lost and those that are in a status of “open” or “forecasted.”
CROs often get repeat business from existing customers. As such, there can be multiple contract opportunities related to a customer. These can include contracts that were won in the past, those that were lost and those that are in a status of “open” or “forecasted.”
There may be different people within a customer or prospect organization who are involved with different contracts.
There may be different people within a customer or prospect organization who are involved with different contracts.
Spreadsheets do not inherently track these relationships.
Spreadsheets do not inherently track these relationships.
With multiple spreadsheet files, there’s no automatic rollup reporting
With multiple spreadsheet files, there’s no automatic rollup reporting
Spreadsheets do not lend themselves to accounting system integration
Spreadsheets do not lend themselves to accounting system integration
Integrating a forecasting system with an accounting system requires mapping the relationships and fields of one structured data repository to another.
Integrating a forecasting system with an accounting system requires mapping the relationships and fields of one structured data repository to another.
Because of the aforementioned partially structured nature of spreadsheets (and possibility that data is in multiple spreadsheets), it’s not practical to set up a regularly scheduled back office system update from a spreadsheet.
Because of the aforementioned partially structured nature of spreadsheets (and possibility that data is in multiple spreadsheets), it’s not practical to set up a regularly scheduled back office system update from a spreadsheet.
User commenting in spreadsheets is very subtle
User commenting in spreadsheets is very subtle
When a comment is added to a spreadsheet, the main evidence is a tiny triangle in the top right corner of a cell. With Excel Online, comments cannot be directed to specific users. Google Sheets does allow for user directed comments along with email notifications.
When a comment is added to a spreadsheet, the main evidence is a tiny triangle in the top right corner of a cell. With Excel Online, comments cannot be directed to specific users. Google Sheets does allow for user directed comments along with email notifications.
How CRM makes revenue forecasting more secure and efficient
How CRM makes revenue forecasting more secure and efficient
At its core, a CRM system like Salesforce (which is what we support) is a structured database. This structure overcomes many of the spreadsheet pitfalls mentioned above.
At its core, a CRM system like Salesforce (which is what we support) is a structured database. This structure overcomes many of the spreadsheet pitfalls mentioned above.
A hierarchal structure
A hierarchal structure
Salesforce has an out of the box hierarchy. A customer or prospect is at the top level. Each company can have multiple related people and multiple related contracts (Opportunities). There can be a secondary association among people and contracts.
Salesforce has an out of the box hierarchy. A customer or prospect is at the top level. Each company can have multiple related people and multiple related contracts (Opportunities). There can be a secondary association among people and contracts.
The Contracts “object” can be customized to accommodate forecast data input. Here is one of the templates that we have set up. A salesperson is responsible for filling in the first section. A sales manager makes adjustments in the second section. The third section is for entering the actual recognized revenue.
The Contracts “object” can be customized to accommodate forecast data input. Here is one of the templates that we have set up. A salesperson is responsible for filling in the first section. A sales manager makes adjustments in the second section. The third section is for entering the actual recognized revenue.
Access Security
Access Security
By default, logging into Salesforce requires two-factor authentication. Anyone logging in from an unfamiliar location and/or device must input an emailed or texted code. For even stricter access security a user can be required to use a mobile authenticator app to get into the database.
By default, logging into Salesforce requires two-factor authentication. Anyone logging in from an unfamiliar location and/or device must input an emailed or texted code. For even stricter access security a user can be required to use a mobile authenticator app to get into the database.
User Permissions
User Permissions
Salesforce allows for different levels of user permissions. For example, a salesperson be set up to only have access to the accounts and associated contracts that he or she is responsible for. A sales manager can have access to all accounts managed by his or her team.
Salesforce allows for different levels of user permissions. For example, a salesperson be set up to only have access to the accounts and associated contracts that he or she is responsible for. A sales manager can have access to all accounts managed by his or her team.
The system is normally set up so that only a sales manager can change the numbers in the forecast adjustment section of a contract opportunity.
The system is normally set up so that only a sales manager can change the numbers in the forecast adjustment section of a contract opportunity.
Data integrity
Data integrity
The fields for capturing month to month figures are defined administratively. A user cannot add new fields they way they can add new columns in a spreadsheet. However, a user can dynamically expose the appropriate number of months for a contract by specifying the number of months in a field.
The fields for capturing month to month figures are defined administratively. A user cannot add new fields they way they can add new columns in a spreadsheet. However, a user can dynamically expose the appropriate number of months for a contract by specifying the number of months in a field.
Rollup reporting & dashboards
Rollup reporting & dashboards
Detail and summary reporting is a standard function of Salesforce. For example, if management wants to see the total monthly amount forecasted and grouped customer and/or by salesperson, that data can be displayed with a simple report.
Detail and summary reporting is a standard function of Salesforce. For example, if management wants to see the total monthly amount forecasted and grouped customer and/or by salesperson, that data can be displayed with a simple report.
When actual revenue is added to a won contract, the delta between what revenue was forecasted and what revenue is recognized can be reported on.
When actual revenue is added to a won contract, the delta between what revenue was forecasted and what revenue is recognized can be reported on.
Back office system integration
Back office system integration
Collaborative commenting
Collaborative commenting
Salesforce Chatter allows for directed commenting along with images, links and file attachments within any record. This means better internal collaboration around contract Opportunities.
Salesforce Chatter allows for directed commenting along with images, links and file attachments within any record. This means better internal collaboration around contract Opportunities.
Through its acquisition of Quip, Salesforce offers an even deeper level of team collaboration.
Through its acquisition of Quip, Salesforce offers an even deeper level of team collaboration.
While spreadsheets are an indispensable business tool, they are not ideal in the long term for revenue forecasting and recognition. A CRM system removes the risks and inefficiencies associated with this application of spreadsheets within Contract Research Organizations.
While spreadsheets are an indispensable business tool, they are not ideal in the long term for revenue forecasting and recognition. A CRM system removes the risks and inefficiencies associated with this application of spreadsheets within Contract Research Organizations.
PART (E)
PART (E)
Global Market for Contract Research Organization (CRO) Services
Global Market for Contract Research Organization (CRO) Services
NEWS PROVIDED BY
Dec 10, 2018, 17:07 ET
SHARE THIS ARTICLE
SHARE THIS ARTICLE
NEW YORK, Dec. 10, 2018 /PRNewswire/ -- Report Scope
NEW YORK, Dec. 10, 2018 /PRNewswire/ -- Report Scope
The Global CRO market is identified in this report along with all major global CRO companies.The total CRO market is broken out globally and by geographic region.
The Global CRO market is identified in this report along with all major global CRO companies.The total CRO market is broken out globally and by geographic region.
Read the full report: https://www.reportlinker.com/p05647308
Read the full report: https://www.reportlinker.com/p05647308
Additionally, all major therapeutic areas covered by CROs in the clinical trial process are detailed.The service areas provided by CROs are extensively covered as well.
Additionally, all major therapeutic areas covered by CROs in the clinical trial process are detailed.The service areas provided by CROs are extensively covered as well.
The phases of the clinical trial process and the role provided by CROs are detailed in this report as well.
The phases of the clinical trial process and the role provided by CROs are detailed in this report as well.
"This report provides detailed analysis of top CRO companies and their evolving role in the clinical trial process. Faced with rapid development of new therapies, Pharmaceutical companies are increasingly turning to CROs for their services. CRO's expertise within specific therapeutic areas as well as their experience with new and adaptive study design protocols, can reduce costs and study duration. With typical clinical trials costing upwards of $2.5 billion and spanning over a decade from initial testing to Phase IV and post market approval, a thriving market exists to lower these costs and timelines. CROs are expected to continue to play an increasingly role in many facets of the clinical trial process. Oncology, neurology, cardiovascular, metabolism-diabetes, vaccines and other rapidly growing therapeutic areas that have a significant number of drugs in the clinical trial process are detailed in this report.
"This report provides detailed analysis of top CRO companies and their evolving role in the clinical trial process. Faced with rapid development of new therapies, Pharmaceutical companies are increasingly turning to CROs for their services. CRO's expertise within specific therapeutic areas as well as their experience with new and adaptive study design protocols, can reduce costs and study duration. With typical clinical trials costing upwards of $2.5 billion and spanning over a decade from initial testing to Phase IV and post market approval, a thriving market exists to lower these costs and timelines. CROs are expected to continue to play an increasingly role in many facets of the clinical trial process. Oncology, neurology, cardiovascular, metabolism-diabetes, vaccines and other rapidly growing therapeutic areas that have a significant number of drugs in the clinical trial process are detailed in this report.
Strong demand for CRO services is leading to heightened market valuations and correspondingly a plethora of blockbuster Merger and Acquisition deals are taking place.M&A activity has led to a few powerful companies with expertise across many areas of the clinical trial process, although many niche players are still playing a critical role.
Strong demand for CRO services is leading to heightened market valuations and correspondingly a plethora of blockbuster Merger and Acquisition deals are taking place.M&A activity has led to a few powerful companies with expertise across many areas of the clinical trial process, although many niche players are still playing a critical role.
These emerging trends and changing dynamics within the CRO industry are analyzed in detail in this report."
These emerging trends and changing dynamics within the CRO industry are analyzed in detail in this report."
Report Includes:
Report Includes:
- 19 tables
- 19 tables
- An overview of the global market for contract research organization (CRO) services
- An overview of the global market for contract research organization (CRO) services
- Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Analyses of the CRO market by services, trial phases, and geographical region
- Analyses of the CRO market by services, trial phases, and geographical region
- Coverage of all major therapeutic areas covered by CROs in the clinical trial process and the types of services they provide
- Coverage of all major therapeutic areas covered by CROs in the clinical trial process and the types of services they provide
- Examination of competitive landscape of the market, including mergers and acquisitions, and current pharma CRO contracts
- Examination of competitive landscape of the market, including mergers and acquisitions, and current pharma CRO contracts
- Company profiles of key market players, including Charles River Laboratories, Icon Plc, Parexel, Pharmaceutical Product Development and Quintiles
- Company profiles of key market players, including Charles River Laboratories, Icon Plc, Parexel, Pharmaceutical Product Development and Quintiles
Summary
Summary
The CRO market continues to exhibit stellar growth, largely attributable to increased demand for services in clinical trials between Phases II and IV, which account for approximately REDACTED of total CROrevenue.All segments, including preclinical and post-approval, continue to grow solidly as well.
The CRO market continues to exhibit stellar growth, largely attributable to increased demand for services in clinical trials between Phases II and IV, which account for approximately REDACTED of total CROrevenue.All segments, including preclinical and post-approval, continue to grow solidly as well.
Outlook for the industry remains extremely positive; with the proliferation of therapies for orphan drugs and precision-based medicines, clinical trials are becoming increasingly complex and are driving demand for sophisticated outsourcing partners with expertise in combination products, risk-based monitoring, disease registries, real world evidence and medical affairs. Expanding service offerings and capabilities remain a predominant strategy among CROs.
Outlook for the industry remains extremely positive; with the proliferation of therapies for orphan drugs and precision-based medicines, clinical trials are becoming increasingly complex and are driving demand for sophisticated outsourcing partners with expertise in combination products, risk-based monitoring, disease registries, real world evidence and medical affairs. Expanding service offerings and capabilities remain a predominant strategy among CROs.
CROs obtain the lion's share of their revenue from actual clinical trials, which accounted for nearly REDACTED in CRO revenue last year. Discovery, preclinical and central lab services all represent strong areas of growth despite accounting for a smaller share of revenue.
CROs obtain the lion's share of their revenue from actual clinical trials, which accounted for nearly REDACTED in CRO revenue last year. Discovery, preclinical and central lab services all represent strong areas of growth despite accounting for a smaller share of revenue.
The geographical distribution of clinical trials is slowly shifting from developed nations to emerging countries; rising costs of trials and difficulty in patient recruitment has led biopharma companies to shift toward regions such as Central and Eastern Europe, Asia-Pacific and Latin America for quicker patient recruitment and cost savings. The greater disease variation among developing countries also helps create more diverse population samples, particularly for rare disease studies.
The geographical distribution of clinical trials is slowly shifting from developed nations to emerging countries; rising costs of trials and difficulty in patient recruitment has led biopharma companies to shift toward regions such as Central and Eastern Europe, Asia-Pacific and Latin America for quicker patient recruitment and cost savings. The greater disease variation among developing countries also helps create more diverse population samples, particularly for rare disease studies.
Based on indication, the oncology segment is the largest and one of the most rapidly growing within the CRO space, with nearly REDACTED spent in 2016 on preclinical and clinical oncology trials. Pain management remains one of the faster growing and more lucrative disease areas, with new treatments for chronic and acute pain and rising investigational studies for Non-Steroidal Anti-Inflammatory Drug (NSAID) and analgesic molecules driving this segment.
Based on indication, the oncology segment is the largest and one of the most rapidly growing within the CRO space, with nearly REDACTED spent in 2016 on preclinical and clinical oncology trials. Pain management remains one of the faster growing and more lucrative disease areas, with new treatments for chronic and acute pain and rising investigational studies for Non-Steroidal Anti-Inflammatory Drug (NSAID) and analgesic molecules driving this segment.
The dominant players in the industry are Quintiles IMS, Covance, PAREXEL, Charles River Labs and ICON. Mergers and acquisitions by these and other larger companies in this space continue at an unprecedented pace; high valuations along with the increasing need to become complete service providers are driving this trend.
The dominant players in the industry are Quintiles IMS, Covance, PAREXEL, Charles River Labs and ICON. Mergers and acquisitions by these and other larger companies in this space continue at an unprecedented pace; high valuations along with the increasing need to become complete service providers are driving this trend.
Key drivers impacting CRO market growth include globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution of technology and greater penetration of CROs into the clinical trial process. The demand or biogenetics and particularly biosimilars will be a clear driver going forward.
Key drivers impacting CRO market growth include globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution of technology and greater penetration of CROs into the clinical trial process. The demand or biogenetics and particularly biosimilars will be a clear driver going forward.
Current pharma R&D spending is being driven by precision-based medicines and immunotherapies for smaller populations, genetic therapies for oncology and rare disease treatment and generally more demanding and complex protocols for drug development.
Current pharma R&D spending is being driven by precision-based medicines and immunotherapies for smaller populations, genetic therapies for oncology and rare disease treatment and generally more demanding and complex protocols for drug development.
The clinical trial environment continues to be tied to exorbitant costs as complex therapies requiring larger and more diverse samples are extending the time required and geographies involved to conduct a typical study. In an effort to contain these costs and shorten development timelines, pharma and biopharma firms are increasingly outsourcing many services associated with the development of today's complex therapies to CROs.
The clinical trial environment continues to be tied to exorbitant costs as complex therapies requiring larger and more diverse samples are extending the time required and geographies involved to conduct a typical study. In an effort to contain these costs and shorten development timelines, pharma and biopharma firms are increasingly outsourcing many services associated with the development of today's complex therapies to CROs.
Read the full report: https://www.reportlinker.com/p05647308
PART (F)
PART (F)
Researcher
Researcher
Share
Working for a university, but only in a part-time capacity? Seeking work with a university? Perhaps you’re bored with your current post, or feel the need to try your luck in another industry without taking a huge risk? Branching out into working as a contract researcher may be for you. Despite current rhetoric about eschewing "experts," government departments rely heavily on the research expertise of academics to gather and analyse data, as do voluntary sector organisations, companies and universities.
Working for a university, but only in a part-time capacity? Seeking work with a university? Perhaps you’re bored with your current post, or feel the need to try your luck in another industry without taking a huge risk? Branching out into working as a contract researcher may be for you. Despite current rhetoric about eschewing "experts," government departments rely heavily on the research expertise of academics to gather and analyse data, as do voluntary sector organisations, companies and universities.
What is a contract researcher?
What is a contract researcher?
When a company, NGO, government office or university department needs to buy in the perfect person to carry out necessary research, contract research staff (CRS, also known as FTCS—fixed-term contract staff) is what they usually go looking for. These posts are generally temporary because they are tied to a specific funding package for the research, whether that’s a research grant or a finite project or plan.
When a company, NGO, government office or university department needs to buy in the perfect person to carry out necessary research, contract research staff (CRS, also known as FTCS—fixed-term contract staff) is what they usually go looking for. These posts are generally temporary because they are tied to a specific funding package for the research, whether that’s a research grant or a finite project or plan.
Experienced university staff and recent MA and PhD students often have precisely the skills that employers and research project managers seek—all you need to do is locate an appropriate possibility and package yourself to fit.
Experienced university staff and recent MA and PhD students often have precisely the skills that employers and research project managers seek—all you need to do is locate an appropriate possibility and package yourself to fit.
Getting the job
Getting the job
Often, CRS posts are advertised; those based within universities almost always are. Begin your search on sites like jobs.ac.uk and with universities in your local area. That said, occasionally university CRS posts go to known colleagues or former students, and are either advertised only briefly or the intended CRS names are included in the funding bid. This means that letting colleagues and former lecturers know you’re seeking contract research work can help—offering to help with putting the bid together is one way to ensure you get a piece of the pie if it succeeds.
Often, CRS posts are advertised; those based within universities almost always are. Begin your search on sites like jobs.ac.uk and with universities in your local area. That said, occasionally university CRS posts go to known colleagues or former students, and are either advertised only briefly or the intended CRS names are included in the funding bid. This means that letting colleagues and former lecturers know you’re seeking contract research work can help—offering to help with putting the bid together is one way to ensure you get a piece of the pie if it succeeds.
Other posts, such as those with NGOs and businesses, may or may not be formally advertised. A charity, for example, may approach an academic whose research is in their field to supervise or carry out a research programme or to write a report based on existing knowledge. Here, contacts are everything—if there are organisations or businesses that operate in your area of expertise or routinely partner with researchers in your current department, find ways to make your ambitions known. Contact-making opportunities include sector conferences and public service task forces.
Other posts, such as those with NGOs and businesses, may or may not be formally advertised. A charity, for example, may approach an academic whose research is in their field to supervise or carry out a research programme or to write a report based on existing knowledge. Here, contacts are everything—if there are organisations or businesses that operate in your area of expertise or routinely partner with researchers in your current department, find ways to make your ambitions known. Contact-making opportunities include sector conferences and public service task forces.
Pros and cons
Pros and cons
Many people find that life on a series of fixed-term contracts comes with its own set of challenges. It can be difficult to obtain a mortgage unless you have a partner in full-time permanent work, for example, and typically the fruits of your labour are the contract givers’, not yours. It’s important to start seeking the next contract around the middle of your current one, and to pursue all opportunities to turn ‘temporary’ into ‘permanent.’
Many people find that life on a series of fixed-term contracts comes with its own set of challenges. It can be difficult to obtain a mortgage unless you have a partner in full-time permanent work, for example, and typically the fruits of your labour are the contract givers’, not yours. It’s important to start seeking the next contract around the middle of your current one, and to pursue all opportunities to turn ‘temporary’ into ‘permanent.’
For those stuck in part-time work or trying to get a foot in the door at a university, however, CRS work can offer an opening. You’ll have to work hard to make the most of it: for example, you may be eligible for tuition fee remission if you’re working for a university, so try to make progress towards a PhD if you don’t have one already. Contract posts can be isolating, so make a point of joining faculty groups and attending research events to maximise your chance of meeting people who can recommend you for a permanent post, or at least another contract.
For those stuck in part-time work or trying to get a foot in the door at a university, however, CRS work can offer an opening. You’ll have to work hard to make the most of it: for example, you may be eligible for tuition fee remission if you’re working for a university, so try to make progress towards a PhD if you don’t have one already. Contract posts can be isolating, so make a point of joining faculty groups and attending research events to maximise your chance of meeting people who can recommend you for a permanent post, or at least another contract.
Tips for new CRSers
Tips for new CRSers
Joining a union can help to protect you (and the rest of us) from poor employment practices. You’ll certainly want to be quite careful about your job description—be clear with your line manager about what you are there to do (research and closely related administration) and what you are not there to do (unrelated administration and, in most cases, staff training or teaching—unless that has been explicitly agreed). Outside of the HE sector, some CRS work is freelance. This can be tricky to negotiate, as you may be offered a flat fee to produce a piece of work rather than an hourly rate or a proper employment contract. If so, consider carefully how many hours may be needed to do the work, and make sure the fee offered is sufficient. Also, make sure you get credit for your work whenever possible, through named authorship or inclusion in the official list of contributors to documents or projects.
Joining a union can help to protect you (and the rest of us) from poor employment practices. You’ll certainly want to be quite careful about your job description—be clear with your line manager about what you are there to do (research and closely related administration) and what you are not there to do (unrelated administration and, in most cases, staff training or teaching—unless that has been explicitly agreed). Outside of the HE sector, some CRS work is freelance. This can be tricky to negotiate, as you may be offered a flat fee to produce a piece of work rather than an hourly rate or a proper employment contract. If so, consider carefully how many hours may be needed to do the work, and make sure the fee offered is sufficient. Also, make sure you get credit for your work whenever possible, through named authorship or inclusion in the official list of contributors to documents or projects.
PART (G)
PART (G)
104,812 Contract Researcher Jobs
104,812 Contract Researcher Jobs
J&J Family of Companies Spring House, PA
Type
Type
Full-Time
Report job
ICON Clinical Research Philadelphia, PA
Type
Type
Full-Time
Report job
The Geo Group Boca Raton, FL
Type
Type
Full-Time
Report job
Quick Apply
Syneos Health Seattle, WA
Benefits
Benefits
VisionMedicalLife Insurance401kDental
Type
Type
Full-Time
Apex Systems Irvine, CA
Type
Type
Full-Time
System One Services Newark, DE
Type
Type
Full-Time
Report job
Quick Apply
Synectics Inc. Lawrenceville, NJ
Pay
Pay
$30 to $32 Hourly
Benefits
Benefits
VisionMedical401kDental
Type
Type
Contractor
IQVIA Wayne, PA
Type
Type
Full-Time
ITRON Liberty Lake, WA
Type
Type
Full-Time
Quick Apply
JBC CONTRACT RESEARCH SERVICES INC San Diego, CA
VisionMedical401kDental
Type
Type
Full-Time
FMC Corporation Newark, DE
Type
Type
Full-Time
FMC Corporation Newark, DE
Type
Type
Full-Time
Report job
GSK Upper Providence Township, PA
Type
Type
Full-Time
Report job
CHOP Philadelphia, PA
Type
Type
Full-Time
GSK Collegeville, PA
Type
Type
Full-Time
Report job
Charles River Laboratories Horsham, PA
Type
Type
Full-Time
Quick Apply
ProEnlist San Francisco, CA
Pay
Pay
$80 to $106 Hourly
Type
Type
Contractor
Report job
J&J Family of Companies Spring House, PA
Type
Type
Full-Time
Report job
Deloitte Philadelphia, PA
Type
Type
Full-Time
Axle Informatics Bethesda, MD
Type
Type
Full-Time
Report job
Load More Job Results
How Much Do Contract ResearchNational Average
How Much Do Contract ResearchNational Average
$19,500$68,139/year$157,000
People Searching Contract Researcher Also Searched
People Searching Contract Researcher Also Searched
Contract Research Research DesignUser Research Contract Development ResearchContract Research Assistant Contract Market Research
Top Cities for Contract Researcher Jobs
Top Cities for Contract Researcher Jobs
Melbourne DavieThornton Murfreesboro Saint Paul North Vancouver Winston-Salem Sunrise Somerville Johns Creek
Top States in US With Contract Researcher Jobs
Top States in US With Contract Researcher Jobs
Georgia Alberta Quebec Connecticut Minnesota Alabama North Carolina Michigan British Columbia Colorado
Human Factors Researcher - Contract
Computer, High tech field
Spring, TX
Contract Length:. Contract Renewal:. Given the contractnature of this position, H1B sponsorship is not available....
Apply instantly
- save job
User Researcher (UX) - Contract
Santa Clara, CA
User Researcher (Contract). 3 years of work experience in an applied research setting as a user researcher applying design thinking methodologies....
- save job
Post-Award Contract Analyst - new
Dallas VA Research Corporation
Dallas, TX 75216 (Cedar Crest area)
$45,000 - $60,000 a year
Post-Award Contract Analyst*. Serve as back-up on Pre-Award Grant and Contract Management tasks, and train colleagues to back up the Post-Award Contract desk....
Apply instantly
- 2 days ago - save job
Cybersecurity Researcher for Small Businesses - new
The Minotaur Group
Washington, DC
We are looking for a contract (1099) cybersecurity researcherthat can help us execute a small business cybersecurity study for a federal agency that will...
Apply instantly
- 1 day ago - save job
DANDELION CORPORATION
Newport Beach, CA
Dandelion Education is seeking PhD level researchers for contract research positions. This is a contract job. Expertise in research methodology required....
30+ days ago - save job - more...
New York, NY 10021 (Upper East Side area)
Contract position:. It is his / her responsibility to partner with the Researcher team to build a robust database, where the Specialists can rely on the...
16 days ago - save job - more...
360 Quote LLC
Tampa Bay, FL
Responsive employer
$13 - $15 an hour
We are looking for people who are open to a long-term project within a team environment. The writer would be responsible for writing a minimum of one article...
Apply instantly
30+ days ago - save job - more...
The Pew Charitable Trusts 53 reviews
Philadelphia, PA 19103
We are a dedicated team of researchers, communicators, advocates, subject matter experts, and professionals working on today’s big challenges – and we know we...
30+ days ago - save job - more...
CitizenDetroit
Detroit, MI 48216 (Millenium Village area)
Responsive employer
Contract Renewal:. This is a contract position with a competitive monthly rate. CitizenDetroit seeks a Researcher/Writer to work with our dynamic, dedicated...
Apply instantly
14 days ago - save job - more...
Falmouth Institute
Fairfax, VA 22030
Contract with Subject Matter Experts to develop and revise course. The Falmouth Institute specializes in professional training for American Indian and Alaska...
Apply instantly
22 days ago - save job - more...
Elections Researcher - new
Elections Researcher - new
Rational Consulting
New York, NY
This is a 1 year (40hrs/wk) contract with potential for extension. Our client is seeking an Elections Researcher to join their Politics & Government Policy team...
2 days ago - save job - more...
Los Angeles, CA +1 location
You’ll have the full support and collaboration of a growing team of researchers in our San Francisco HQ. Opendoor is looking for an experienced mixed-methods...
22 days ago - save job - more...
New York, NY
Must be a strong communicator, solid researcher, critical thinker and problem solver for situations with multiple complex issues where a sensible, strategic...
20 days ago - save job - more...
Las Vegas, NV 89109
Associate Producer / Researcher (Contract Position). This position is an initial 2 year contract position with the potential to extend....
Apply instantly
30+ days ago - save job - more...
SJR Research LLC
Gettysburg, PA
Work directly with project manager, researcher, and designer/printer to develop a high-quality book. Contractwriters will be hired on a per-project basis and...
Apply instantly
- save job
Knovva Academy
Boston, MA 02210 (South Boston area)
The Academic Researcher is a 1099 contract position. Contract Length:. Contract Renewal:. Researchers should have special experience in one or more of the...
Apply instantly
- save job
THE RESEARCH REPORT:
HARRIS MANAGEMENT, LLP
HARRIS MANAGEMENT, LLP
